Dr. Andrea Del Valle Gil Guevara, MD

Dr. Gil Guevara practices at Spartanburg Medical Center in Spartanburg, South Carolina, part of Spartanburg Regional Healthcare System.

Dr. Gil Guevara's NPI, 1467948927, was assigned on July 9, 2018. Dr. Gil Guevara holds South Carolina license 90574.

Dr. Gil Guevara's primary practice is Spartanburg Medical Center, at 101 E Wood St, Spartanburg, SC 29303 in Spartanburg County. The practice phone is (864) 560-6554.

Dr. Gil Guevara's primary practice is Spartanburg Medical Center in Spartanburg, South Carolina, part of Spartanburg Regional Healthcare System. Dr. Gil Guevara is also affiliated with Pelham Medical Center. The medical group on file is Medical Group of the Carolinas - Family Medicine - Converse Heights. Dmand AI also links Dr. Gil Guevara to 2 more hospitals and 1 group practice or clinic, each named with a free account. Dr. Gil Guevara's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gil Guevara practices, 5 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Gil Guevara's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dmand AI has Dr. Gil Guevara's licenses on file in 2 states: South Carolina and Texas.

CMS data shows 576 Medicare services from Dr. Gil Guevara across 8 procedure codes in 2024, for 336 Medicare patients. Medicare paid $49,997 for them.

CMS counts 336 Medicare patients who saw Dr. Gil Guevara in 2024. The largest group is 65 to 74, with 139 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 21% are also on Medicaid. Their average risk score is 1.81, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gil Guevara's median patient age at 67, with 61% women.

In 2024, Dr. Gil Guevara wrote 1,769 Medicare Part D claims for 319 patients. 84% of them were for generic drugs. CMS names the drug for 1,547 of them, across 43 drugs with 11 or more claims each, at $239,203 in total drug cost. In 2023, CMS named 72 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Gil Guevara for performance year 2024, reported through an alternative payment model (APM). Dr. Gil Guevara accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 14 procedures of skin biopsy by Dr. Gil Guevara, more than 61% of the clinicians it reports for that procedure.

Dmand AI links 3 papers to Dr. Gil Guevara, published from 2020 to 2025. Dr. Gil Guevara's most frequent co-authors are Bhanu Gogia, MD, Ferhat Erol, MD and Xiang Fang, MD, PhD.

CMS Open Payments shows 192 general payments to Dr. Gil Guevara from 41 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 91% of the total. LivaNova USA, Inc. paid the most, $950.